Eye Health / Blindness News From Medical News Today
Latest Health News and Medical News posted throughout the day, every day.
5 Sep 2010 at 2:00am
Alcon, Inc. (NYSE: ACL), the world's leader in eye care and cataract surgery, announced its launch of the AcrySof® IQ ReSTOR® Multifocal Toric intraocular lens (IOL) outside the United States during the 2010 European Society of Cataract and Refractive Surgeons (ESCRS) annual meeting in Paris, France...
4 Sep 2010 at 4:00am
As many children head back to school this fall, are they truly prepared for what lies ahead? With a few simple medical exams; Maine's school-age children will be armed with the tools they need to have a healthier school year...
3 Sep 2010 at 7:00am
Twenty-first-century pharmaceutical breakthroughs require 21st-century drug discovery tools, such as computational or in silico molecular design and high-throughput screening of effective, new compounds. That's the theme of a University at Buffalo symposium to be held Sept...
3 Sep 2010 at 6:00am
It's back to school time! Kids are feeling excited and maybe a little nervous. New teachers, new friends and new sports seasons. Parents are scrambling to buy back-to-school clothes and equip their children with all the sports gear they need, like helmets, pads, braces and mouth guards...
3 Sep 2010 at 5:00am
Carl Zeiss Meditec is once again presenting its expanded offer of solutions for cataract, refractive and retina applications. Under the theme - Creating what's to come - the company is demonstrating how it would like to shape the future of ophthalmology with its products and solutions...
3 Sep 2010 at 4:00am
Global ophthalmic device company OptiMedica Corp. has announced that clinical results for its laser cataract surgical system will be the subject of three presentations at the European Society of Cataract and Refractive Surgeons annual meeting in Paris, September 4 - 8...
2 Sep 2010 at 8:00am
All 12 TLC Laser Eye Centers in Southern California are changing their names to NVISION Laser Eye Centers. The name change accompanies the sale of TLC Vision's interest in the 12 centers to Medical Director Dr. Tom Tooma to become a separate LASIK brand. The new brand will operate as NVISION Laser Eye Centers and will have the same 12 Southern California locations, same surgeons and staff...
2 Sep 2010 at 6:00am
Bausch + Lomb Storz® Ophthalmic Instruments announces the U.S. release of a new, single-use, asymmetric peeling forceps for vitreoretinal surgery. The forceps are available in 23- and 25-gauge options for facilities seeking the safety, consistency and convenience a single-use instrument offers...
2 Sep 2010 at 6:00am
Eye M.D.s are intent on finding better ways to diagnose and treat glaucoma, a complex, potentially blinding disease. September's Ophthalmology journal includes new data from the Rotterdam Study that will help doctors better predict visual field loss (VFL) in glaucoma patients. Johannes R...
2 Sep 2010 at 4:00am
A recent study conducted by oculoplastic surgeon Charles Soparkar, M.D., Ph.D. (The Methodist Hospital, Houston, TX) utilizing a patent-pending formulation of zinc and phytase (trademarked as ZYTAZE™), demonstrated that increasing zinc levels by oral administration for 4 days prior to a planned injection of botulinum toxin improved efficacy and/or duration in 41 of 44 patients tested (93%)...
2 Sep 2010 at 4:00am
ReVision Therapeutics Inc. announced that data from a Phase 2b trial show that fenretinide (RT-101) reduced the incidence of choroidal neovascularization (CNV, wet age related macular degeneration) by about 50 percent in patients with geographic atrophy (GA), the most advanced form of dry age related macular degeneration (AMD). The data, presented Monday by Alexander M. Eaton, M.D...
2 Sep 2010 at 4:00am
ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer announces that its second Phase III trial evaluating microplasmin for the non-surgical treatment of vitreomacular adhesion (VMA) has met its primary endpoint...
2 Sep 2010 at 3:00am
pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release back of the eye drug delivery systems for difficult-to-treat conditions, announced that its licensee, Alimera Sciences (NASDAQ:ALIM) has been notified that the U.S...
2 Sep 2010 at 2:00am
Allergan, Inc. (NYSE:AGN) announced the United States Food and Drug Administration (FDA) has approved LUMIGAN® (bimatoprost ophthalmic solution) 0.01% as a first-line therapy indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. LUMIGAN® 0...
1 Sep 2010 at 6:00am
A new imaging system using six different wavelengths to illuminate the interior of the eyeball (ocular fundus) may pave the way for doctors to easily screen patients for common diseases of the eye, such as age-related macular degeneration and diabetic retinopathy. The system is described in the journal Review of Scientific Instruments, which is published by the American Institute of Physics...
